aod9604 clinical trials weight loss efficacy results Data from the Phase 2 Trial of CX11/VCT220 in China Presented at ADA 2025 – Press releases – CORXEL Pharmaceuticals AOD-9604 Before and After: Results

Easy-to-take oral capsule format eliminates the need for injectionsoffering a convenient approach to metabolic support and cellular optimization

Choosing between topical and injectable GHK-Cu Whether you go with a topical or an injectable form of GHK-Cu is a discussion best had with your doctor, who can guide you to the right option based on your medical needs and history

Lin P, Owens R, Tricot G, Wilson CS

This experiment confirmed that the product can delay systemic aging by regulating NAD+ metabolism, providing in vivo evidence for anti-aging interventions

Lyophilised AOD-9604 should be stored at 20 C protected from light, stability 2 to 3 years

resell or transfer products for prohibited use